FDA Inspection 1168720 — K2M, Inc.
The FDA completed an inspection of K2M, Inc. on April 21, 2022 in Leesburg, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 21, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Leesburg, VA (United States)